Fat-induced jejunal inhibition of gastric acid secretion and release of pancreatic glucagon, enteroglucagon, gastric inhibitory polypeptide, and vasoactive intestinal polypeptide in man.
The effect of intrajejunal (i.j.) infusion of fat on meal-stimulated gastric acid secretion and release of pancreatic glucagon (PG), enteroglucagon (EG), gastric inhibitory polypeptide (GIP), and vasoactive intestinal polypeptide (VIP) was studied in seven healthy volunteers. I.j. fat markedly inhibited meal-stimulated acid secretion as compared to a control study with i.j. saline infusion. The acid inhibition was accompanied by augmental plasma concentrations of EG, GIP, and VIP but not of PG, suggesting that EG, GIP, and VIP may be among mediators of fat-induced jejunal inhibition of acid secretion. Concentration-time relationship makes it unlikely that the observed inhibition could be ascribed to any single peptide studied.
D000328:Adult; D004041:Dietary Fats / Q000008:administration & dosage; D004750:Enteral Nutrition; D005749:Gastric Inhibitory Polypeptide / Q000097:blood / Q000378:metabolism*; D005750:Gastric Juice / Q000378:metabolism*; D005768:Gastrointestinal Hormones / Q000378:metabolism*; D005934:Glucagon / Q000097:blood / Q000378:metabolism*; D004763:Glucagon-Like Peptides / Q000097:blood / Q000378:metabolism*; D006801:Humans; D007583:Jejunum / Q000502:physiology*; D008297:Male; D012636:Secretory Rate; D014660:Vasoactive Intestinal Peptide / Q000097:blood / Q000378:metabolism*
D004041:Dietary Fats; D005768:Gastrointestinal Hormones; D014660:Vasoactive Intestinal Peptide; D005749:Gastric Inhibitory Polypeptide; D004763:Glucagon-Like Peptides; D005934:Glucagon